ORKA
NASDAQ
$94.32
ARCA biopharma Inc (ORKA)
Oruka Therapeutics, Inc. is a biotechnology company.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $144.67 (+53.38%)
Market Cap
$4.35B
FCF 5Y CAGR
+51.87%
Free Cash Flow Yield
-2.10%
Price Chart
Valuation
Market Cap$4.35B
P/B10.54
Profitability
EBITDA-$133M
EPS-$2.52
Financial Health
Free Cash Flow Yield-2.10%
Growth & Risk
EPS 5Y CAGR+11.91%
FCF 5Y CAGR+51.87%
Sharpe Ratio2.74